Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Integra LifeSciences Holdings Corporation (IART) had Return on Tangible Equity of 73.12% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$1.64B |
|
$-516.47M |
|
$803.62M |
|
$831.62M |
|
$2.13B |
|
$-493.37M |
|
$-70.13M |
|
$-563.50M |
|
$-563.50M |
|
$-516.47M |
|
$-516.47M |
|
$-516.47M |
|
$-516.47M |
|
$-493.37M |
|
$-335.93M |
|
76.67M |
|
76.67M |
|
$-6.74 |
|
$-6.74 |
|
| Balance Sheet Financials | |
$1.16B |
|
$444.33M |
|
$2.44B |
|
$3.60B |
|
$455.98M |
|
$1.73B |
|
$2.10B |
|
$2.56B |
|
$1.04B |
|
$-706.36M |
|
$1.04B |
|
77.89M |
|
| Cash Flow Statement Financials | |
$50.38M |
|
$-108.06M |
|
$28.34M |
|
$246.38M |
|
$235.05M |
|
$-11.33M |
|
$18.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.54 |
|
-- |
|
-- |
|
0.62 |
|
1.78 |
|
50.86% |
|
-30.17% |
|
-30.17% |
|
-20.54% |
|
-34.46% |
|
-31.58% |
|
$-31.05M |
|
-- |
|
-- |
|
-- |
|
0.45 |
|
1.63 |
|
5.86 |
|
62.24 |
|
-49.50% |
|
|
Return on Tangible Equity |
73.12% |
-14.34% |
|
-18.62% |
|
$13.40 |
|
$-0.41 |
|
$0.66 |
|